Construction of PAMAM-based Nanocomplex Conjugated with Pt(IV)-complex and Lauric Acid Exerting Both Anti-tumor and Antibacterial Effects

You-Tao Xin; Lu-Yao Wang; Huan-Huan Chang; Fei-He Ma; Ming-Lei Sun; Li Chen; Hui Gao

doi:10.1007/s10118-023-2890-x

Your Location：

Home >

Browse articles >

Construction of PAMAM-based Nanocomplex Conjugated with Pt(IV)-complex and Lauric Acid Exerting Both Anti-tumor and Antibacterial Effects

RESEARCH ARTICLE | Updated：2023-05-26

- Construction of PAMAM-based Nanocomplex Conjugated with Pt(IV)-complex and Lauric Acid Exerting Both Anti-tumor and Antibacterial Effects
- Chinese Journal of Polymer Science Vol. 41, Issue 6, Pages: 887-896(2023)
- Affiliations：
  
  a.State Key Laboratory of Separation Membranes and Membrane Processes, School of Materials Science and Engineering, Tiangong University, Tianjin 300387, China
  b.School of Chemistry and Chemical Engineering, Tianjin Key Laboratory of Drug Targeting and Bioimaging, Tianjin Enterprise Key Laboratory for Application Research of Hyaluronic Acid, Tianjin University of Technology, Tianjin 300384, China
- Author bio：
  
  feihema@tiangong.edu.cn (F.H.M.)
  huigao@tiangong.edu.cn (H.G.)
- Funds：
- DOI：10.1007/s10118-023-2890-x
  CLC：
- Received：17 September 2022，
  
  Revised：2022-10-19，
  
  Accepted：20 October 2022，
  
  Online First：12 December 2022，
  
  Published：01 June 2023
- Accepted：
Scan QR Code
Xin, Y. T.; Wang, L. Y.; Chang, H. H.; Ma, F. H.; Sun, M. L.; Chen, L.; Gao, H. Construction of PAMAM-based nanocomplex conjugated with Pt(IV)-complex and lauric acid exerting both anti-tumor and antibacterial effects. Chinese J. Polym. Sci. 2023, 41, 887–896

You-Tao Xin, Lu-Yao Wang, Huan-Huan Chang, et al. Construction of PAMAM-based Nanocomplex Conjugated with Pt(IV)-complex and Lauric Acid Exerting Both Anti-tumor and Antibacterial Effects[J]. Chinese Journal of Polymer Science, 2023, 41(6): 887-896.
Xin, Y. T.; Wang, L. Y.; Chang, H. H.; Ma, F. H.; Sun, M. L.; Chen, L.; Gao, H. Construction of PAMAM-based nanocomplex conjugated with Pt(IV)-complex and lauric acid exerting both anti-tumor and antibacterial effects. Chinese J. Polym. Sci. 2023, 41, 887–896 DOI： 10.1007/s10118-023-2890-x.

You-Tao Xin, Lu-Yao Wang, Huan-Huan Chang, et al. Construction of PAMAM-based Nanocomplex Conjugated with Pt(IV)-complex and Lauric Acid Exerting Both Anti-tumor and Antibacterial Effects[J]. Chinese Journal of Polymer Science, 2023, 41(6): 887-896. DOI： 10.1007/s10118-023-2890-x.

摘要

A novel polymeric nanocomplex with anti-tumour and antibacterial dual-functions was synthesized to treat Fusobacterium nucleatum (

)-infected colorectal cancer. This novel nanocomplex effectively reverses

-induced drug resistance

providing a powerful strategy for the treatment of bacterial related cancers.

Abstract

Oxaliplatin is the common chemotherapy drug for the treatment of colorectal cancer (CRC)

however

the harmful Fusobacterium nucleatum (

) that existed in the CRC tumor tissues leads to extreme drug resistance to oxaliplatin

which reduces the anticancer efficiency. Here we fabricated a new dendrimer-based nanocomplex with anti-tumor and antibacterial dual-functions through conjugating Pt(IV)-complex and lauric acid (LA) to the dendritic carrier PAMAM (G=3). The synthesized PAMAM-Pt-LA nanoparticle was further coated with hyaluronic acid (HA) on its surface through electrostatically interaction in order to enhance biocompatibility and tumor targeting. The biocompatibility

anti-tumor activity and antibacterial activity of PAMAM-Pt-LA@HA nanocomplex were evaluated

in vitro

. The results showed that the PAMAM-Pt-LA@HA nanocomplex ehxibited a good biocompatibility

high anti-colorectal cancer activity and high anti-

activity. This dual-functional nanocomplex provides a new method to develop anticancer nanomedicines that will be more therapeutically efficacious and less toxic than oxaliplatin for the treatment of CRC.

关键词

Keywords

references

Siegel,R.L.;Miller,K.D.;Fedewa,S.A.;Ahnen,D.J.;Meester,R.G.S.;Barzi,A.;Jemal,A.Colorectalcancerstatistics,2017. CA Cancer J. Clin. 2017 , 67 ,177−193..

Bray,F.;Jemal,A.;Grey,N.;Ferlay,J.;Forman,D.GlobalcancertransitionsaccordingtotheHumanDevelopmentIndex(2008−2030):apopulation-basedstudy. Lancet Oncol. 2012 , 13 ,790−801..

Haggar,F.A.;Boushey,R.P.Colorectalcancerepidemiology:incidence,mortality,survival,andriskfactors. Clin. Colon. Rectal. Surg. 2009 , 22 ,191−197..

Kasi,P.M.;Grothey,A.Chemotherapymaintenance. Cancer J. 2016 , 22 ,199−204..

Sandler,A.;Schiller,J.H.;Johnson,D.H.Paclitaxel-carboplatinaloneorwithbevacizumabfornon-small-celllungcancer. N. Engl. J. Med. 2006 , 355 ,2542−2550..

Wall,M.E.;Wani,M.C.CamptothecinandTaxol:discoverytoClinic-ThirteenthBruceF. Cain Memorial Award Lecture. Cancer Res. 1995 , 55 ,753−760..

Oberlies,N.H.;Kroll,D.J.CamptothecinandTaxol:historicachievementsinnaturalproductsresearch. J. Nat. Prod. 2004 , 67 ,129−135..

Sommerfeld,N.S.;Hejl,M.;Klose,M.H.M.;Schreiber-Brynzak,E.;Bileck,A.;Meier,S.M.;Gerner,C.;Jakupec,M.A.;Galanski,M.;Keppler,B.K.Low-generationpolyamidoaminedendrimersasdrugcarriersforplatinum(IV)complexes. Eur. J. Inorg. Chem. 2017 , 2017 ,1713−1720..

Marques,M.P.M.Platinumandpalladiumpolyaminecomplexesasanticanceragents:thestructuralfactor. ISRN Spectrosc. 2013 , 13 ,287353..

Wu,Y.L.;Engl,W.;Hu,B.;Cai,P.;Leow,W.R.;Tan,N.S.;Lim,C.T.;Chen,X.Nanomechanicallyvisualizingdrug-cellinteractionattheearlystageofchemotherapy. ACS Nano. 2017 , 11 ,6996−7005..

Chen,H.;Zhang,W.;Zhu,G.;Xie,J.;Chen,X.Rethinkingcancernanotheranostics. Nat. Rev. Mater. 2017 , 2 ,17024..

Nguyen,C.K.;Tran,N.Q.;Nguyen,T.P.;Nguyen,D.H.Biocompatiblenanomaterialsbasedondendrimers,hydrogelsandhydrogelnanocompositesforuseinbiomedicine. Adv. Nat. Sci:Nanosci. Nanotechnol. 2017 , 8 ,015001..

Luong,D.;Kesharwani,P.;Deshmukh,R.;MohdAmin,M.C.I.;Gupta,U.;Greish,K.;Iyer,A.K.PEGylatedPAMAMdendrimers:enhancingefficacyandmitigatingtoxicityforeffectiveanticancerdrugandgenedelivery. Acta Biomater. 2016 , 43 ,14−29..

Nguyen,D.H.;Lee,J.S.;Choi,J.H.;Park,K.M.;Lee,Y.;Park,K.D.Hierarchicalself-assemblyofmagneticnanoclustersfortheranostics:tunablesize,enhancedmagneticresonanceimagability,andcontrolledandtargeteddrugdelivery. Acta Biomater. 2016 , 35 ,109−117..

Liu,Y.;Baba,Y.;Ishimoto,T.;Iwatsuki,M.;Hiyoshi,Y.;Miyamoto,Y.;Yoshida,N.;Wu,R.;Baba,H.ProgressincharacterizingthelinkagebetweenFusobacteriumnucleatumandgastrointestinalcancer. J. Gastroenterol. 2019 , 54 ,33−41..

Luo,K.;Zhang,Y.;Xv,C.;Ji,J.;Lou,G.;Guo,X.;Chen,M.;Zhang,Y.;Wei,H.;Guo,M.;Huang,R.;Yu,S.Fusobacteriumnucleatum,thecommunicationwithcolorectalcancer. Biomed. Pharmacother. 2019 , 116 ,108988..

RouseMark,S.;Rotger,M.;PiperKerryl,E.;SteckelbergJames,M.;Scholz,M.;Andrews,J.;Patel,R. In vitro and in vivo evaluationsoftheactivitiesoflauricacidmonoesterformulationsagainstStaphylococcusaureus. Antimicrob. Agents Chemother. 2005 , 49 ,3187−3191..

Mattheolabakis,G.;Milane,L.;Singh,A.;Amiji,M.M.HyaluronicacidtargetingofCD44forcancertherapy:fromreceptorbiologytonanomedicine. J. Drug Target. 2015 , 23 ,605−618..

Park,J.H.;Cho,H.J.;Yoon,H.Y.;Yoon,I.S.;Ko,S.H.;Shim,J.S.;Cho,J.H.;Park,J.H.;Kim,K.;Kwon,I.C.;Kim,D.D.Hyaluronicacidderivative-coatednanohybridliposomesforcancerimaginganddrugdelivery. J. Control Rel. 2014 , 174 ,98−108..

Yan,X.;Chen,Q.;An,J.;Liu,D.E.;Huang,Y.;Yang,R.;Li,W.;Chen,L.;Gao,H.Hyaluronicacid/PEGylatedamphiphilicnanoparticlesforpursuitofselectiveintracellulardoxorubicinrelease. J. Mater. Chem. B. 2019 , 7 ,95−102..

Buczkowski,A.;Waliszewski,D.;Urbaniak,P.;Palecz,B.StudyoftheinteractionsofPAMAMG3-NH2andG3-OHdendrimerswith5-fluorouracilinaqueoussolutions. Int. J. Pharm. 2016 , 505 ,1−13..

Golombek,S.K.;May,J.-N.;Theek,B.;Appold,L.;Drude,N.;Kiessling,F.;Lammers,T.Tumortargeting via EPR:strategiestoenhancepatientresponses. Adv. Drug Deliv. Rev. 2018 , 130 ,17−38..

Ding,Y.;Xu,Y.;Yang,W.;Niu,P.;Li,X.;Chen,Y.;Li,Z.;Liu,Y.;An,Y.;Liu,Y.;Shen,W.;Shi,L.InvestigatingtheEPReffectofnanomedicinesinhumanrenaltumors via ex vivo perfusionstrategy. Nano Today 2020 , 35 ,100970..

Kang,H.;Rho,S.;Stiles,W.R.;Hu,S.;Baek,Y.;Hwang,D.W.;Kashiwagi,S.;Kim,M.S.;Choi,H.S.Size-dependentEPReffectofpolymericnanoparticlesontumortargeting. Adv. Healthc. Mater. 2020 , 9 ,1901223..

Sindhwani,S.;Syed,A.M.;Ngai,J.;Kingston,B.R.;Maiorino,L.;Rothschild,J.;MacMillan,P.;Zhang,Y.;Rajesh,N.U.;Hoang,T.;Wu,J.L.Y.;Wilhelm,S.;Zilman,A.;Gadde,S.;Sulaiman,A.;Ouyang,B.;Lin,Z.;Wang,L.;Egeblad,M.;Chan,W.C.W.Theentryofnanoparticlesintosolidtumours. Nat. Mater. 2020 , 19 ,566−575..

Park,J.;Choi,Y.;Chang,H.;Um,W.;Ryu,J.H.;Kwon,I.C.AlliancewithEPReffect:combinedstrategiestoimprovetheEPREffectinthetumormicroenvironment. Theranostics 2019 , 9 ,8073−8090..

Lv,Y.;Xu,C.;Zhao,X.;Lin,C.;Yang,X.;Xin,X.;Zhang,L.;Qin,C.;Han,X.;Yang,L.;He,W.;Yin,L.NanoplatformassembledfromaCD44-targetedprodrugandsmartliposomesfordualtargetingoftumormicroenvironmentandcancercells. ACS Nano 2018 , 12 ,1519−1536..

Cheng,T.;Ma,R.;Zhang,Y.;Ding,Y.;Liu,J.;Ou,H.;An,Y.;Liu,J.;Shi,L.Asurface-adaptivenanocarriertoprolongcirculationtimeandenhancecellularuptake. Chem. Commun. 2015 , 51 ,14985−14988..

Sun,Q.;Zhou,Z.;Qiu,N.;Shen,Y.Rationaldesignofcancernanomedicine:nanopropertyintegrationandsynchronization. Adv. Mater. 2017 , 29 ,1606628..

Chen,W.;Lian,W.;Yuan,Y.;Li,M.Thesynergisticeffectsofoxaliplatinandpiperlongumineoncolorectalcanceraremediatedbyoxidativestress. Cell Death Dis. 2019 , 10 ,600..

Circu,M.L.;Aw,T.Y.Reactiveoxygenspecies,cellularredoxsystems,andapoptosis. Free Radic. Biol. Med. 2010 , 48 ,749−762..

Masuda,H.;Tanaka,T.;Takahama,U.CisplatingeneratessuperoxideanionbyinteractionwithDNAinacell-freesystem. Biochem. Biophys. Res. Commun. 1994 , 203 ,1175−1180..

Godwin,A.K.;Meister,A.;O'Dwyer,P.J.;Huang,C.S.;Hamilton,T.C.;Anderson,M.E.Highresistancetocisplatininhumanovariancancercelllinesisassociatedwithmarkedincreaseofglutathionesynthesis. Proc. Natl. Acad. Sci. U. S. A. 1992 , 89 ,3070−3074..

FischerCarol,L.;DrakeDavid,R.;DawsonDeborah,V.;BlanchetteDerek,R.;BrogdenKim,A.;WertzPhilip,W.Antibacterialactivityofsphingoidbasesandfattyacidsagainstgram-positiveandgram-negativebacteria. Antimicrob. Agents Chemother. 2012 , 56 ,1157−1161..

Haas,S.;Hain,N.;Raoufi,M.;Handschuh-Wang,S.;Wang,T.;Jiang,X.;Schönherr,H.Enzymedegradablepolymersomesfromhyaluronicacid-block-poly( ε -caprolactone)copolymersforthedetectionofenzymesofpathogenicbacteria. Biomacromolecules 2015 , 16 ,832−841..

Hynes,W.L.;Walton,S.L.HyaluronidasesofGram-positivebacteria. FEMS Microbiol. Lett. 2000 , 183 ,201−207..

Views

216

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Tumor-Penetrating and Mitochondria-Targeted Drug Delivery Overcomes Doxorubicin Resistance in Lung Cancer

Antimicrobial Properties and Application of Polysaccharides and Their Derivatives

Durable Anti-fogging and Abrasion-resistant Coatings Based on Polyoxometalates-Hydrophilic Resin Composites with Enhanced Cohesion and Adhesion

Improvements of Hydrophobicity and Toughness of Epoxy Coatings Modified with Hydroxyl-terminated Fluororubber

Bioinspired Zinc-doped Nano Hydroxyapatite Reinforced Poly(lactic acid) Composites for Bone Repair

Related Author

Yi Hu

Jia-Yu Zhang

Meng-Xue Zhou

Xiao-Meng Cai

Rui Dou

Li-Fo Ruan

Wen-Jiang Yang

Wen-Chu Lin

Related Institution

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics and University of Chinese Academy of Sciences (UCAS), Chinese Academy of Sciences (CAS)

Key Laboratory of Tea Biology and Resource Utilization of Ministry of Agriculture, Tea Research Institute, Chinese Academy of Agricultural Sciences

Division of Nuclear Technology and Applications, Institute of High Energy Physics, Chinese Academy of Sciences (CAS)

High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China, University of Science and Technology of China

State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology

⁰